title: Primary stenting produces earlier and more efficient myocardial reperfusion than primary PTCA alone in patients with acute ST segment elevation MI.
abstract: Restoration of blood flow in the infarct-related artery and subsequent myocardial reperfusion are major goals of both thrombolysis and primary percutaneous interventions. Whether percutaneous transluminal coronary angioplasty (PTCA) with immediate stenting (primary stenting) produces reperfusion more rapidly than primary PTCA alone is uncertain. This study determines whether primary stenting produces earlier myocardial reperfusion than primary PTCA alone in patients with acute ST segment elevation myocardial infarction using troponin T release kinetics. Primary stenting was performed on 60 patients and primary PTCA alone on 44 patients with typical ischemic chest pain and greater than 1.5 MV ST segment elevation in more than 2 contiguous electrocardiographic leads. Serum troponin T concentrations were measured before and after intervention; every 6 hours for 24 hours; then at 36, 48 and 72 hours. The mean time from onset of chest pain to peak serum troponin T concentration was 7.8 +/- 2.7 hours after primary stenting and 14.5 +/- 4.4 hours after primary PTCA (p < 0.0005). The mean peak serum troponin T concentration was 9.8 +/- 6.3 ng/dL after primary stenting and 13.6 +/-6.4 ng/dL after primary PTCA (p < 0.012). A significant univariate association with time to peak concentration of serum troponin T was identified for primary stenting (p < 0.0005), time from onset of chest pain to intervention (p < 0.04), and diabetes mellitus (p < 0.01). The only significant univariate marker associated with peak concentration of serum troponin T was primary stenting (p < 0.012). Multivariate analysis indicated that primary stenting (p < 0.0005), time from onset of chest pain to intervention (p < 0.048), and diabetes mellitus (p < 0.022) significantly influenced time to peak serum concentration or troponin T. Primary stenting produces earlier myocardial reperfusion than primary PTCA in patients with acute ST segment elevation myocardial infarction.
authors.affiliation: Department of Cardiology, University of Athens Hospital, Athens, Greece.
authors.forename: Apostolis J
authors.initials: AJ
authors.lastname: Karavidas
authors.forename: Antony D
authors.initials: AD
authors.lastname: Vrachatis
authors.forename: Martin A
authors.initials: MA
authors.lastname: Alpert
authors.forename: Dimitris J
authors.initials: DJ
authors.lastname: Nikas
authors.forename: Dimitrious J
authors.initials: DJ
authors.lastname: Achtypis
authors.forename: Masolis G
authors.initials: MG
authors.lastname: Foukarakis
authors.forename: Evangelos P
authors.initials: EP
authors.lastname: Matsakus
authors.forename: Costas S
authors.initials: CS
authors.lastname: Thedocharis
authors.forename: Apostolos A
authors.initials: AA
authors.lastname: Zacharoulis
mesh_terms: D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D003925:Diabetic Angiopathies / Q000097:blood / Q000628:therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009203:Myocardial Infarction / Q000097:blood / Q000628:therapy*; D015607:Stents; D016896:Treatment Outcome; D020107:Troponin T / Q000097:blood
chemical_list: D020107:Troponin T